Gretchen G. Kimmick, MD, MS, discusses selecting adjuvant therapy for patients with HER2-positive breast cancer.
Gretchen G. Kimmick, MD, MS
Advertisement
Articles by Gretchen G. Kimmick, MD, MS
Gretchen G. Kimmick, MD, MS, discusses the quickly evolving treatment paradigm for patients with HER2-positive breast cancer.
Gretchen G. Kimmick, MD, MS, discusses the results of the phase 2 ATEMPT trial in early-stage HER2-positive breast cancer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
2
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
3
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
4
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
5